Clinical Research Directory

Inclusion Criteria: 1. Providing written informed consent 2. Males and females of at least 18 years old 3. Minimum 4 weeks on GLP-1 (f.e Ozempic®, Wegovy®, Mounjaro®, etc.) and maximum 1 year on GLP-1 4. Body Mass Index (BMI) ≥ 25 AND ≤ 30 5. Being willing to maintain stable dietary habits and physical activity levels throughout the trial period 6. Being willing not to introduce any other food supplements during the trial period (supplements used in the two weeks prior to enrolling in the trial and used consistently throughout are acceptable, except for probiotics). Exclusion Criteria: 1. Having had any type of bariatric surgery, or planned bariatric surgery during the period of trial participation. 2. Suffering from a severe chronic disease (e.g., cancer, HIV, hepatic or renal impairment, diabetes type I), inflammatory bowel disease (IBD), Coeliac Disease, and/or being immunocompromised. 3. Suffering from any uncontrolled endocrine disorder 4. Having used any antibiotic treatment in the 2 months prior to enrollment. 5. Having a known allergy to the ingredients in the study product. 6. Being pregnant or lactating (breastfeeding) or trying to become pregnant. 7. Participating in another clinical trial. 8. Suffering from dementia or inability to take the trial treatment in an appropriate way. 9. Taking PhytoMulti® Multivitamin and/or UltraFlora® Probiotic or any similar product from competitors prior to trial participation